iSGLT2 Clinical Trials

1 actively recruiting trial

Also known as: SGLT2 inhibitor

Pipeline

Phase 2: 1

Top Sponsors

Maximo Agustin Schiavone1

Indications

Chronic Kidney Disease Requiring Hemodialysis1
Heart Disease1

Other1 trial

Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.